[Cyclophosphane treatment of patients with partial red cell aplasia].

[Increase in NETO2 gene expression is a potential molecular genetic marker in renal and lung cancers]. Genetika (2012) 0.84

[Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas]. Mol Biol (Mosk) (2010) 0.83

[Stimulation of proliferation by carnosine: cellular and transcriptome approaches]. Mol Biol (Mosk) (2015) 0.78

[Genetic diversity and evolution of the influenza C virus]. Genetika (2012) 0.76

[Colony-forming capacity of bone marrow cells in patients with hypoplastic anemia]. Gematol Transfuziol (1984) 0.75

[Transition of hypoplastic anemia into acute leukemia]. Probl Gematol Pereliv Krovi (1968) 0.75

[Hemopoiesis in hypoplastic and aplastic anemia according to the puncture material and sections of bone marrow trephination material]. Probl Gematol Pereliv Krovi (1967) 0.75

[Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia]. Ter Arkh (2010) 0.75

[Molecular characterization of pandemic influenza viruses A/H1N1(sw2009) isolated in Russia in 2009-2010]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75

[Thrombocyte ultrastructural and functional characteristics in hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1981) 0.75

[A method of differentiated combined treatment of patients with hypoplastic anemia after splenectomy]. Gematol Transfuziol (1983) 0.75

[Preparation stimulating hair growth possibly acts by inhibiting hair follicle ageing experiments on mice and transcriptome analysis]. Adv Gerontol (2014) 0.75

[Effect of combined treatment on erythrocyte life span in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75

[Myelocytic leukemia transformed into reticulosarcomatosis]. Ter Arkh (1976) 0.75

[Diagnostic value of the study of material of trephine biopsies in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75

[Basic principles of blood transfusion therapy in splenectomy on hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1978) 0.75

[Complications of an ulcerative-necrotic lesion of the gastrointestinal tract in hemoblastosis patients]. Probl Gematol Pereliv Krovi (1981) 0.75

[The use of cyclophosphane in the immunodepressive therapy of severe aplastic anemia]. Ter Arkh (1997) 0.75

[Bacterial flora and certain indicators of nonspecific reactivity of the body in hypo-aplastic anemias]. Probl Gematol Pereliv Krovi (1973) 0.75

[Differentiated therapy of hypoplastic anemia patients in relation to the immunomorphological status of their bone marrow]. Gematol Transfuziol (1985) 0.75

[Tactics of the surgeon during performance of splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1968) 0.75

[Prevention and treatment of hemodynamic disorders in subacute hypoplastic anemia after splenectomy]. Probl Gematol Pereliv Krovi (1976) 0.75

[Clinico-immunologic aspects of idiopathic neutropenias]. Klin Med (Mosk) (1990) 0.75

[Determination of the activity of the pathologic process in hypoplastic (aplastic) anemia]. Gematol Transfuziol (1993) 0.75

[Pathogenesis of the development of fibroreticular tissue in patients with chronic myeloleukemia]. Gematol Transfuziol (1988) 0.75

[Electron microscopic characteristics of bone marrow lymphocytes in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1978) 0.75

[Polymorphism of KPI-A genes from plants of the subgenus Potatoe (sect. Petota, Estolonifera and Lycopersicum) and subgenus Solanum]. Mol Biol (Mosk) (2013) 0.75

[Successful treatment of a patient having partial hypoplastic anemia with cyclophosphan]. Probl Gematol Pereliv Krovi (1976) 0.75

[Treatment principles and procedure in hypoplastic anemia]. Sov Med (1981) 0.75

[The role of splenectomy in treating severe aplastic anemia]. Gematol Transfuziol (1996) 0.75

[Phagocytosis and bactericidal properties of the blood serum in hypoplastic hemopoiesis]. Ter Arkh (1970) 0.75

[Characteristics of the immunohematological indicators in patients with hypoplastic anemia during remission]. Gematol Transfuziol (1983) 0.75

[Vitamin B 12 and serum protein content of the blood in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1970) 0.75

[Valve of the radioisotope method of study in the determination of indications for splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75

[Levamisole in the treatment of hypoplastic anemia]. Gematol Transfuziol (1984) 0.75

[Methylation of DNA in Streptomyces coeruleorubidus cells]. Dokl Akad Nauk SSSR (1991) 0.75

[Splenectomy in the treatment of hypo- and aplastic anemia]. Sov Med (1970) 0.75

[Pandemic influenza A/H1N1 (sw2009) in Russia: epidemiology, diagnosis, clinical picture, and treatment]. Ter Arkh (2010) 0.75

[New trends in the treatment of hypoplastic anemia]. Klin Med (Mosk) (1985) 0.75

[Granulocyte ultrastructure in patients with hypoplastic anemia]. Gematol Transfuziol (1983) 0.75

[Change in the immunoglobulins and nonspecific defense factors in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75

[Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid]. Ter Arkh (2000) 0.75

[Bone marrow transplantation in the treatment of aplastic anemia patients]. Ter Arkh (1993) 0.75

[Indications for using androgens in hypoplastic anemia]. Gematol Transfuziol (1984) 0.75

[Surgical results with hematologic patients]. Vestn Khir Im I I Grek (1982) 0.75